China approves use of Cuban drug to treat pancreatic cancer
por Nimotuzumab, a medicine developed by Cuba’s Center for Molecular Immunology (CIM), was approved in China for the treatment of pancreatic cancer, after a phase III clinical study.
Etiqueta: drug
Cuba resumes some drug production lines
With the arrival in Cuba of some quantities of financed supplies, and other efforts, drugs in high demand by the population are now in production, confirmed Rita Maria Garcia, director of Operations and Technology of the Biocubafarma Business Group.